MediWound Ltd. Statistics
Share Statistics
MediWound Ltd. has 10.79M shares outstanding. The number of shares has increased by 13.64% in one year.
| Shares Outstanding | 10.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.23M |
| Failed to Deliver (FTD) Shares | 1.40K |
| FTD / Avg. Volume | 2.66% |
Short Selling Information
The latest short interest is 593.04K, so 5.5% of the outstanding shares have been sold short.
| Short Interest | 593.04K |
| Short % of Shares Out | 5.5% |
| Short % of Float | 8.2% |
| Short Ratio (days to cover) | 18.59 |
Valuation Ratios
The PE ratio is -13.65 and the forward PE ratio is -7.62.
| PE Ratio | -13.65 |
| Forward PE | -7.62 |
| PS Ratio | 4.91 |
| Forward PS | 6.5 |
| PB Ratio | 2.9 |
| P/FCF Ratio | -5.41 |
| PEG Ratio | n/a |
Enterprise Valuation
MediWound Ltd. has an Enterprise Value (EV) of 86.34M.
| EV / Earnings | -12.86 |
| EV / Sales | 4.62 |
| EV / EBITDA | -17.65 |
| EV / EBIT | -5.65 |
| EV / FCF | -5.1 |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.
| Current Ratio | 4.59 |
| Quick Ratio | 4.33 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -35.81 |
Financial Efficiency
Return on equity (ROE) is -0.21% and return on capital (ROIC) is -41.44%.
| Return on Equity (ROE) | -0.21% |
| Return on Assets (ROA) | -0.1% |
| Return on Capital (ROIC) | -41.44% |
| Revenue Per Employee | 186.86K |
| Profits Per Employee | -67.16K |
| Employee Count | 100 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 5.31 |
Taxes
| Income Tax | 185.00K |
| Effective Tax Rate | -0.03 |
Stock Price Statistics
The stock price has increased by 48.41% in the last 52 weeks. The beta is 0.84, so MediWound Ltd.'s price volatility has been higher than the market average.
| Beta | 0.84 |
| 52-Week Price Change | 48.41% |
| 50-Day Moving Average | 17.33 |
| 200-Day Moving Average | 17.34 |
| Relative Strength Index (RSI) | 61.9 |
| Average Volume (20 Days) | 52.53K |
Income Statement
In the last 12 months, MediWound Ltd. had revenue of 18.69M and earned -6.72M in profits. Earnings per share was -0.75.
| Revenue | 18.69M |
| Gross Profit | 3.58M |
| Operating Income | -15.29M |
| Net Income | -6.72M |
| EBITDA | -4.89M |
| EBIT | -15.29M |
| Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 11.87M in cash and 6.35M in debt, giving a net cash position of 5.52M.
| Cash & Cash Equivalents | 11.87M |
| Total Debt | 6.35M |
| Net Cash | 5.52M |
| Retained Earnings | -174.82M |
| Total Assets | 74.73M |
| Working Capital | 28.31M |
Cash Flow
In the last 12 months, operating cash flow was -10.46M and capital expenditures -6.46M, giving a free cash flow of -16.93M.
| Operating Cash Flow | -10.46M |
| Capital Expenditures | -6.46M |
| Free Cash Flow | -16.93M |
| FCF Per Share | -1.88 |
Margins
Gross margin is 19.15%, with operating and profit margins of -81.83% and -35.94%.
| Gross Margin | 19.15% |
| Operating Margin | -81.83% |
| Pretax Margin | -34.95% |
| Profit Margin | -35.94% |
| EBITDA Margin | -26.19% |
| EBIT Margin | -81.83% |
| FCF Margin | -90.6% |
Dividends & Yields
MDWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3.93% |
| FCF Yield | -8.22% |
Analyst Forecast
The average price target for MDWD is $25, which is 30.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $25 |
| Price Target Difference | 30.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 20, 2022. It was a forward split with a ratio of 7:1.
| Last Split Date | Dec 20, 2022 |
| Split Type | forward |
| Split Ratio | 7:1 |
Scores
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 1 |